In Vivo comparative evaluation of early- and late-stage ACLT-hMnX rat models: a case study of avidin as a cartilage-penetrating nanocarrier for disease-modifying osteoarthritis drugs

Luca Morici, Eric Allémann, Olivier Jordan

Open source

DOI
10.3389/fphar.2026.1877598
Published
2026-08-26
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1877598,
  title = {In Vivo comparative evaluation of early- and late-stage ACLT-hMnX rat models: a case study of avidin as a cartilage-penetrating nanocarrier for disease-modifying osteoarthritis drugs},
  author = {Luca Morici and Eric Allémann and Olivier Jordan},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1877598},
  url = {https://doi.org/10.3389/fphar.2026.1877598}
}

RIS

TY  - JOUR
TI  - In Vivo comparative evaluation of early- and late-stage ACLT-hMnX rat models: a case study of avidin as a cartilage-penetrating nanocarrier for disease-modifying osteoarthritis drugs
AU  - Luca Morici
AU  - Eric Allémann
AU  - Olivier Jordan
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1877598
UR  - https://doi.org/10.3389/fphar.2026.1877598
ER  - 

APA

Morici, L., Allémann, E., & Jordan, O. (2026). In Vivo comparative evaluation of early- and late-stage ACLT-hMnX rat models: a case study of avidin as a cartilage-penetrating nanocarrier for disease-modifying osteoarthritis drugs. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1877598

Source records